Exponent (EXPO)
(Delayed Data from NSDQ)
$91.91 USD
-1.29 (-1.38%)
Updated Apr 30, 2024 04:00 PM ET
After-Market: $91.85 -0.06 (-0.07%) 7:58 PM ET
1-Strong Buy of 5 1
F Value B Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$91.91 USD
-1.29 (-1.38%)
Updated Apr 30, 2024 04:00 PM ET
After-Market: $91.85 -0.06 (-0.07%) 7:58 PM ET
1-Strong Buy of 5 1
F Value B Growth B Momentum C VGM
Zacks News
Mastercard (MA) Ties Up To Hasten Checkouts in UK and Europe
by Zacks Equity Research
Mastercard (MA) teams up with DNA Payments to unveil Click to Pay to benefit merchants and consumers across the UK and Europe with increased choice, speed and security in transactions.
Should SPDR S&P 600 Small Cap ETF (SLY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SLY
Should Vanguard S&P Small-Cap 600 ETF (VIOO) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VIOO
Franklin Covey (FC) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Franklin Covey (FC) delivered earnings and revenue surprises of 14.29% and 1.53%, respectively, for the quarter ended November 2022. Do the numbers hold clues to what lies ahead for the stock?
Should Vanguard S&P SmallCap 600 Growth ETF (VIOG) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VIOG
Mastercard (MA) Ties Up for Virtual Card Uptake in Travel Space
by Zacks Equity Research
Mastercard (MA) joins forces with Sabre and Conferma Pay to facilitate payments in the travel ecosystem. MA also decides to buy a minority stake in Conferma Pay.
Franklin Covey Company (FC) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Franklin Covey (FC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Exponent (EXPO) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Exponent (EXPO) delivered earnings and revenue surprises of 11.90% and 1%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Should Vanguard S&P SmallCap 600 Growth ETF (VIOG) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VIOG
Mastercard (MA) Adds Experts to Client Services Team in Egypt
by Zacks Equity Research
Mastercard (MA) inflates the base of its Advisors Client Services Hub in Egypt by expanding the panel of experts at the site. This will boost MA to serve its global clients with professional ease.
Exponent (EXPO) Q2 Earnings Surpass Estimates
by Zacks Equity Research
Exponent (EXPO) delivered earnings and revenue surprises of 8.89% and 0.26%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
After Plunging 22.8% in 4 Weeks, Here's Why the Trend Might Reverse for Exponent (EXPO)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Exponent (EXPO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Here's Why Exponent (EXPO) is Poised for a Turnaround After Losing 19.9% in 4 Weeks
by Zacks Equity Research
Exponent (EXPO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Here's Why Exponent (EXPO) is Poised for a Turnaround After Losing 16.5% in 4 Weeks
by Zacks Equity Research
Exponent (EXPO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Here's Why Exponent (EXPO) is Poised for a Turnaround After Losing 14.6% in 4 Weeks
by Zacks Equity Research
Exponent (EXPO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Exponent (EXPO) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Exponent (EXPO) delivered earnings and revenue surprises of 7.69% and 2.05%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for March 4th
by Zacks Equity Research
AMED, CACC, and EXPO have been added to the Zacks Rank #5 (Strong Sell) List on March 4, 2022
Exponent (EXPO) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Exponent (EXPO) delivered earnings and revenue surprises of 5.56% and 2.14%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Exponent (EXPO) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Exponent (EXPO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Franklin Covey (FC) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Franklin Covey (FC) delivered earnings and revenue surprises of 800% and 10.64%, respectively, for the quarter ended November 2021. Do the numbers hold clues to what lies ahead for the stock?
Exponent (EXPO) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Exponent (EXPO) delivered earnings and revenue surprises of 15.00% and 3.83%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Exponent (EXPO) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Exponent (EXPO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FTI Consulting (FCN) Appoints New Senior Managing Director
by Zacks Equity Research
FTI Consulting (FCN) welcomes Jim Wrynn to the position of senior managing director in its Global Insurance Services practice.
Exponent (EXPO): Strong Industry, Solid Earnings Estimate Revisions
by Aditi Saraogi
Exponent (EXPO) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Are You Looking for a Top Momentum Pick? Why Exponent (EXPO) is a Great Choice
by Zacks Equity Research
Does Exponent (EXPO) have what it takes to be a top stock pick for momentum investors? Let's find out.